Search

Search bills, members, committees and pages...

CELANESE CORPORATION

34 federal lobbying filings, 2023 to 2026.

CELANESE CORPORATION is a client on 34 federal lobbying filings, 2023 to 2026, reporting $1.1M across them. Chemical & specialty materials company Based in Texas.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

3 it has hired, by filings.

RegistrantFilingsReported
HOLLAND & KNIGHT LLP16$1.1M
CELANESE CORPORATION14
CROWELL & MORING LLP4

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20264$170K$900K
20259$400K$1.4M
20248$270K$1.4M
202313$290K$1.5M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
TAXTaxation/Internal Revenue Code27
CHMChemicals/Chemical Industry24
TRDTrade (domestic/foreign)15
SCIScience/Technology14
TRATransportation14
ENVEnvironment/Superfund10
FOOFood Industry (safety, labeling, etc.)6
CAWClean Air and Water (quality)2
ENGEnergy/Nuclear2

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1415No IRIS Act of 20256
H.R. 640Chemical Tax Repeal Act6
H.R. 8998Researching Innovative Shipbuilding and Next-Generation Transit Infrastructure for Durable and Efficient Syst…6
S. 615Chemical Tax Repeal Act6
S. 623No IRIS Act of 20256
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.5
H.R. 4754Department of the Interior, Environment, and Related Agencies Appropriations Act, 20264
H.R. 8398Guidelines for Use, Access, and Responsible Disclosure of Financial Data Act4
S. 2104Reliable Rail Service Act of 20254
S. 3122Better FDA Act of 20253
H.R. 8101Ensuring Better Interest Treatment and Deductibility Act (EBITDA)2
H.R. 928Railway Safety Act of 20252
S. 4221Ensuring Better Interest Treatment and Deductibility Act (EBITDA)2
S. 576One Flag for All Act2
H.R. 4958GRAS Act1
H.R. 8870BUILD America 250 Act1
S. 4397Sound Science Act of 20261

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
CELANESE CORPORATIONCELANESE CORPORATION2026 second_quarter$460KJul 21, 2026
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2026 second_quarter$90KJul 17, 2026
CELANESE CORPORATIONCELANESE CORPORATION2026 first_quarter$440KApr 21, 2026
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2026 first_quarter$80KApr 19, 2026
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2025 fourth_quarter$80KApr 9, 2026
CELANESE CORPORATIONCELANESE CORPORATION2025 fourth_quarter$300KJan 21, 2026
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2025 fourth_quarter$80KJan 18, 2026
CELANESE CORPORATIONCELANESE CORPORATION2025 third_quarter$310KOct 21, 2025
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2025 third_quarter$80KOct 17, 2025
CELANESE CORPORATIONCELANESE CORPORATION2025 second_quarter$320KJul 22, 2025
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2025 second_quarter$80KJul 15, 2025
CELANESE CORPORATIONCELANESE CORPORATION2025 first_quarter$490KApr 21, 2025
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2025 first_quarter$80KApr 15, 2025
CELANESE CORPORATIONCELANESE CORPORATION2024 fourth_quarter$370KJan 22, 2025
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2024 fourth_quarter$80KJan 20, 2025
CELANESE CORPORATIONCELANESE CORPORATION2024 third_quarter$420KOct 22, 2024
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2024 third_quarter$70KOct 17, 2024
CELANESE CORPORATIONCELANESE CORPORATION2024 second_quarter$240KJul 23, 2024
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2024 second_quarter$60KJul 14, 2024
CELANESE CORPORATIONCELANESE CORPORATION2024 first_quarter$340KApr 23, 2024
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2024 first_quarter$60KApr 15, 2024
CELANESE CORPORATIONCELANESE CORPORATION2023 fourth_quarter$380KJan 22, 2024
CELANESE CORPORATIONHOLLAND & KNIGHT LLP2023 fourth_quarter$60KJan 20, 2024
CELANESE CORPORATIONCROWELL & MORING LLP2023 fourth_quarterJan 4, 2024
CELANESE CORPORATIONCELANESE CORPORATION2023 third_quarter$320KOct 20, 2023